Introduction
Methods
Design and data sources
Setting
Identification of the study cohort
Variables
Exposure
Outcomes
Characteristics of study population
Statistical analysis
Results
Patient characteristics | AI n (%) | CIIDA n (%) | IDA n (%) | Other n (%) | Unclassified n (%) | Total n (%) |
---|---|---|---|---|---|---|
Total, n (%)a | 2640 (5.4) | 639 (1.3) | 7674 (15.7) | 4570 (9.3) | 33,402 (68.3) | 48,925 (100.0) |
Age groups, years | ||||||
40–49 | 165 (6.3) | 83 (13.0) | 3386 (44.1) | 555 (12.1) | 4211 (12.6) | 8400 (17.2) |
50–59 | 362 (13.7) | 68 (10.6) | 1355 (17.7) | 825 (18.1) | 4773 (14.3) | 7383 (15.1) |
60–69 | 657 (24.9) | 142 (22.2) | 981 (12.8) | 1037 (22.7) | 7054 (21.1) | 9871 (20.2) |
70–79 | 835 (31.6) | 180 (28.2) | 1127 (14.7) | 1185 (25.9) | 9424 (28.2) | 12,751 (26.1) |
80–89 | 621 (23.5) | 166 (26.0) | 825 (10.8) | 968 (21.2) | 7940 (23.8) | 10,520 (21.5) |
Anaemia severity b | ||||||
Mild | 1984 (75.2) | 445 (69.6) | 3244 (42.3) | 3871 (84.7) | 28,742 (86.0) | 38,286 (78.3) |
Moderate | 620 (23.5) | 181 (28.3) | 3883 (50.6) | 658 (14.4) | 4302 (12.9) | 9644 (19.7) |
Severe | 36 (1.4) | 13 (2.0) | 547 (7.1) | 41 (0.9) | 358 (1.1) | 995 (2.0) |
Civil status | ||||||
Living with a partner | 1454 (55.1) | 315 (49.3) | 4372 (57.0) | 2609 (57.1) | 18,730 (56.1) | 27,480 (56.2) |
Living alone | 1186 (44.9) | 324 (50.7) | 3302 (43.0) | 1961 (42.9) | 14,672 (43.9) | 21,445 (43.8) |
Educational level | ||||||
Low | 1203 (45.6) | 333 (52.1) | 2905 (37.9) | 1893 (41.4) | 14,798 (44.3) | 21,132 (43.2) |
Medium | 1003 (38.0) | 215 (33.6) | 2888 (37.6) | 1787 (39.1) | 12,773 (38.2) | 18,666 (38.2) |
High | 434 (16.4) | 91 (14.2) | 1881 (24.5) | 890 (19.5) | 5831 (17.5) | 9127 (18.7) |
Income | ||||||
Low | 996 (37.7) | 248 (38.8) | 1988 (25.9) | 1535 (33.6) | 11,484 (34.4) | 16,251 (33.2) |
Medium | 859 (32.5) | 217 (34.0) | 2342 (30.5) | 1424 (31.2) | 11,274 (33.8) | 16,116 (32.9) |
High | 785 (29.7) | 174 (27.2) | 3344 (43.6) | 1611 (35.3) | 10,644 (31.9) | 16,558 (33.8) |
No. of comorbidities | ||||||
0 | 1516 (57.4) | 309 (48.4) | 5185 (67.6) | 2484 (54.4) | 16,909 (50.6) | 26,403 (54.0) |
1 | 592 (22.4) | 150 (23.5) | 1379 (18.0) | 1111 (24.3) | 8238 (24.7) | 11,470 (23.4) |
2 | 350 (13.3) | 105 (16.4) | 696 (9.1) | 650 (14.2) | 5246 (15.7) | 7047 (14.4) |
≥ 3 | 182 (6.9) | 75 (11.7) | 414 (5.4) | 325 (7.1) | 3009 (9.0) | 4005 (8.2) |
Sex | ||||||
Men | 1612 (61.1) | 259 (40.5) | 1448 (18.9) | 2885 (63.1) | 20,944 (62.7) | 27,148 (55.5) |
Women | 1028 (38.9) | 380 (59.5) | 6226 (81.1) | 1685 (36.9) | 12,458 (37.3) | 21,777 (44.5) |
Type of comorbidity c | ||||||
Arthritis | 38 (1.4) | 6 (0.9) | 52 (0.7) | 47 (1.0) | 343 (1.0) | 486 (1.0) |
Cardiovascular disease | 606 (23.0) | 164 (25.7) | 1177 (15.3) | 1126 (24.6) | 9100 (27.2) | 12,173 (24.9) |
COPD | 170 (6.4) | 75 (11.7) | 302 (3.9) | 224 (4.9) | 2072 (6.2) | 2843 (5.8) |
Diabetes | 190 (7.2) | 73 (11.4) | 575 (7.5) | 397 (8.7) | 3697 (11.1) | 4932 (10.1) |
Hypertension | 522 (19.8) | 152 (23.8) | 1086 (14.2) | 979 (21.4) | 7865 (23.5) | 10,604 (21.7) |
IBD | 17 (0.6) | 12 (1.9) | 72 (0.9) | 47 (1.0) | 334 (1.0) | 482 (1.0) |
Liver disease | 46 (1.7) | 20 (3.1) | 78 (1.0) | 64 (1.4) | 417 (1.2) | 625 (1.3) |
Mental illness | 190 (7.2) | 69 (10.8) | 606 (7.9) | 368 (8.1) | 3060 (9.2) | 4293 (8.8) |
Neurological disorder | 68 (2.6) | 20 (3.1) | 136 (1.8) | 150 (3.3) | 1082 (3.2) | 1456 (3.0) |
Kidney disease | 44 (1.7) | 12 (1.9) | 50 (0.7) | 68 (1.5) | 592 (1.8) | 766 (1.6) |
Incidence proportion
Standardised incidence ratios
Associations between patient characteristics and cancer
Patient characteristics | AI HRa (95% CI) | CIIDA HRa (95% CI) | IDA HRa (95% CI) | Other HRa (95% CI) | Unclassified HRa (95% CI) |
---|---|---|---|---|---|
Events, n (%)b,c Person years | 446 (13.6%) 2118 | 103 (3.1%) 528 | 429 (13.1%) 7239 | 255 (7.8%) 4295 | 2052 (62.5%) 30,923 |
Age groups, years | |||||
40–49 | 1 | 1 | 1 | 1 | 1 |
50–59 | 1.58 (0.90–2.76) | 2.50 (0.78–7.98) | 3.34 (2.06–5.39) | 3.37 (1.49–7.63) | 3.10 (2.31–4.17) |
60–69 | 2.14 (1.27–3.62) | 3.68 (1.35–10.06) | 11.77 (7.64–18.14) | 6.39 (2.92–13.98) | 6.51 (4.95–8.56) |
70–79 | 2.46 (1.46–4.16) | 9.50 (3.48–25.98) | 18.32 (11.96–28.09) | 6.95 (3.14–15.34) | 7.24 (5.51–9.51) |
80–89 | 1.86 (1.08–3.23) | 3.70 (1.25–10.94) | 16.81 (10.74–26.30) | 7.41 (3.31–16.59) | 6.05 (4.59–8.00) |
Anaemia severity d | |||||
Mild | 1 | 1 | 1 | 1 | 1 |
Moderate | 1.87 (1.49–2.35) | 2.00 (1.31–3.06) | 1.87 (1.49–2.34) | 2.43 (1.75–3.37) | 2.87 (2.54–3.25) |
Severe | 3.66 (2.09–6.40) | 1.22 (0.29–5.11) | 4.05 (3.07–5.36) | 2.72 (1.01–7.35) | 6.47 (5.10–8.21) |
Civil status | |||||
Living alone | 1 | 1 | 1 | 1 | 1 |
Living with a partner | 1.10 (0.89–1.35) | 0.98 (0.66–1.46) | 1.13 (0.92–1.39) | 1.17 (0.88–1.55) | 1.03 (0.94–1.13) |
Educational level | |||||
Low | 1 | 1 | 1 | 1 | 1 |
Medium | 1.18 (0.96–1.46) | 1.80 (1.15–2.81) | 1.08 (0.86–1.35) | 1.50 (1.12–2.01) | 1.11 (1.00–1.23) |
High | 1.04 (0.77–1.40) | 1.36 (0.69–2.67) | 1.40 (1.05–1.86) | 1.23 (0.84–1.81) | 1.08 (0.94–1.24) |
Income | |||||
Low | 1 | 1 | 1 | 1 | 1 |
Medium | 1.08 (0.85–1.36) | 0.62 (0.38–1.04) | 0.82 (0.64–1.04) | 0.95 (0.68–1.31) | 0.89 (0.80–0.99) |
High | 0.99 (0.76–1.29) | 0.95 (0.53–1.30) | 0.88 (0.67–1.16) | 1.17 (0.84–1.64) | 0.91 (0.80–1.03) |
No. of comorbidities e | |||||
0 | 1 | 1 | 1 | 1 | 1 |
1 | 0.48 (0.37–0.63) | 0.48 (0.28–0.81) | 0.70 (0.55–0.89) | 0.64 (0.46–0.88) | 0.77 (0.69–0.86) |
2 | 0.62 (0.46–0.85) | 0.58 (0.33–1.03) | 0.52 (0.38–0.72) | 0.71 (0.49–1.03) | 0.60 (0.52–0.69) |
≥ 3 | 0.44 (0.28–0.71) | 0.25 (0.10–0.64) | 0.59 (0.40–0.87) | 0.48 (0.26–0.86) | 0.54 (0.45–0.65) |
Sex | |||||
Men | 1 | 1 | 1 | 1 | 1 |
Women | 0.68 (0.54–0.84) | 0.69 (0.45–1.04) | 0.44 (0.36–0.54) | 0.61 (0.45–0.83) | 0.60 (0.53–0.67) |